Anaïs Roeser
LightNews LightNews
anaisroeser.bsky.social
Anaïs Roeser
@anaisroeser.bsky.social
56 followers 140 following 1 posts
MD, internal medicine
PhD candidate, Mahévas Lab, @NeckerINEM
#immunology
Posts Replies Media Videos
Reposted by Anaïs Roeser
revmedinterne.bsky.social
Jeunes internistes, ce programme est fait pour vous ! Envoyez vos candidatures !

@ajinternistes.bsky.social
October 12, 2025 at 3:56 PM
Reposted by Anaïs Roeser
acr-journals.bsky.social
Assessing risk of adverse pregnancy outcomes among women with SSc in the Swedish Medical Birth Register showed increased risk of preeclampsia, preterm birth, and caesarean delivery. Increased risk was also noted in the 3 years before SSc diagnosis

A&R
doi.org/10.1002/art....
#Medsky #OBsky
Relative risks (RR) with 95% confidence intervals (CI) of adverse pregnancy outcomes in pregnancies in post-SSc pregnancies compared with comparator-pregnancies 1998-2021
July 14, 2025 at 8:23 PM
Reposted by Anaïs Roeser
kerrijohannson.bsky.social
Incidence, Prevalence, and Mortality of Interstitial Lung Diseases in Alberta, Canada: A Population-based Study

www.atsjournals.org/doi/suppl/10...

🧵👇

📣 TL:DR Incidence stable, prevalence rising, improved survival for ILD & IPF over 10 years.
Numbers much higher than prior reports for ILD & IPF.
Screenshot of title of study and authorship
July 4, 2025 at 2:35 PM
Reposted by Anaïs Roeser
revmedinterne.bsky.social
Le 90ème Congrès #SNFMI débute demain à #Vichy
snfmivichy2025.com

Découvrez d'ores et déjà l'ensemble des résumés de Communications dans notre Numéro spécial Congrès : www.sciencedirect.com/journal/la-r...
La Revue de Médecine Interne | 90e CONGRÈS FRANÇAIS DE MÉDECINE INTERNE - Vichy, 25 au 27 juin 2025 | ScienceDirect.com by Elsevier
Read the latest articles of La Revue de Médecine Interne at ScienceDirect.com, Elsevier’s leading platform of peer-reviewed scholarly literature
www.sciencedirect.com
June 24, 2025 at 4:10 PM
Reposted by Anaïs Roeser
nejm.org
Two patients had autoimmune hemolytic anemia that relapsed after CD19 CAR T-cell therapy but responded rapidly to BCMA-targeted T-cell–engager therapy with remission, minimal side effects, and hematologic improvement. Learn more: nej.md/3SM6S4V

#MedSky #Immunology
The clinical responses in Patients 1 and 2 before and after the first dose of CM336 through 6 months.
June 16, 2025 at 4:01 PM
Reposted by Anaïs Roeser
nejm.org
In the FIBRONEER-IPF phase 3 trial, nerandomilast slowed disease progression in patients with idiopathic pulmonary fibrosis as compared with placebo. Full trial results and Research Summary: nej.md/4mgWcIU 

#MedSky #PulmSky #CriticalCare
The New England Journal of Medicine Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis A Research Summary based on Richeldi L et al. | 10.1056/NEJMoa2414108 | Published on May 18, 2025 Visual representations of the patients in the trial and the treatments they were assigned. Read the full Research Summary at NEJM.org.
June 16, 2025 at 7:36 PM
Reposted by Anaïs Roeser
revmedinterne.bsky.social
ℹ️ Mise au point
👀Uvéites associées aux maladies auto-inflammatoires (ROSAH, Blau, NEMO, CAPS...), pour les découvrir c'est par ici 👉
www.sciencedirect.com/science/arti...
June 4, 2025 at 5:32 PM
Reposted by Anaïs Roeser
revmedinterne.bsky.social
ℹ️ Mise au point
Neurolymphomatoses : retrouvez une synthèse complète sur cette complication rare des hémopathies. Neuropathologie, tableaux cliniques et électrophysiologiques évocateurs, stratégies diagnostiques: c’est par ici 👉 www.sciencedirect.com/science/arti...

#neurolymphomatose #neuropathie
May 26, 2025 at 2:11 PM
Reposted by Anaïs Roeser
revmedinterne.bsky.social
🖼️Portrait
Découvrez Alexandre Belot, PUPH en rhumatologie pédiatrique et co-coordinateur de la filière FAI2R, ainsi que son regard sur la médecine interne et son avenir.

www.sciencedirect.com/science/arti...
Portrait du Pr Alexandre Belot, PU-PH en rhumatologie pédiatrique au CHU de Lyon, co-coordinateur de la filière FAI2R
www.sciencedirect.com
May 21, 2025 at 7:24 PM
Reposted by Anaïs Roeser
nejm.org
In the FIBRONEER-IPF phase 3 trial, nerandomilast slowed disease progression in patients with idiopathic pulmonary fibrosis as compared with placebo. Full trial results: nej.md/4mgWcIU

#ATS2025 @atscommunity.bsky.social
A bar chart showing the change from baseline in forced vital capacity at week 52 in the overall trial population
May 18, 2025 at 9:20 PM
Reposted by Anaïs Roeser
revmedinterne.bsky.social
⚖️ Inauguration de la rubrique « Controverse » ce mois ci dans la Revue de Médecine Interne

www.sciencedirect.com/science/arti...
La « Controverse », l’heure du staff dans la revue de médecine interne
www.sciencedirect.com
May 7, 2025 at 2:07 PM
Reposted by Anaïs Roeser
revmedinterne.bsky.social
⚖️ Faut il traiter le lymphome du MALT dans la maladie de Sjögren?

✅Pour?
www.sciencedirect.com/science/arti...

🚫Contre?
www.sciencedirect.com/science/arti...
« Faut-il traiter le lymphome du MALT dans la maladie de Sjögren ? » : le pour
www.sciencedirect.com
May 7, 2025 at 2:10 PM
Reposted by Anaïs Roeser
revmedinterne.bsky.social
Revue 📑
Du JC virus au Covid-19 : redécouvrez les complications virales associées aux biothérapies et thérapies ciblées, ainsi que leurs mesures de prévention dans cette revue de la littérature.
👉 www.sciencedirect.com/science/arti...
Complications virales des biothérapies/thérapies ciblées anti-inflammatoires
Depuis la fin des années 1990 sont apparues de nouvelles options thérapeutiques immunomodulatrices impactant les déterminants de nombreuses affections…
www.sciencedirect.com
March 10, 2025 at 6:51 PM
Reposted by Anaïs Roeser
revmedinterne.bsky.social
Revue 📑
Ce mois-ci, retrouvez une revue de la littérature ainsi que le Protocole National de Soins sur la prise en charge du syndrome de Cogan
#Cogan #PNDS #vascularite
👉 www.sciencedirect.com/science/arti...
French protocol for diagnosis and management of Cogan's syndrome
Cogan's syndrome is a condition of unknown origin, classified as a systemic vasculitis. It is characterised by a predilection for the cornea and the i…
www.sciencedirect.com
March 3, 2025 at 8:10 AM
Reposted by Anaïs Roeser
revmedinterne.bsky.social
Learn all about Cogan syndrome and its treatment approach with a literature review and the French national protocol for diagnosis and management
👉 www.sciencedirect.com/science/arti...

#Cogan #syndrome #vasculitis #guidelines #review
French protocol for diagnosis and management of Cogan's syndrome
Cogan's syndrome is a condition of unknown origin, classified as a systemic vasculitis. It is characterised by a predilection for the cornea and the i…
www.sciencedirect.com
March 3, 2025 at 8:18 AM
Reposted by Anaïs Roeser
revmedinterne.bsky.social
Éditorial
Les printemps de la médecine interne ont 30 ans : les diagnosticiens à l’honneur
🌻🌷
www.sciencedirect.com/science/arti...
Les printemps de la médecine interne ont 30 ans : les diagnosticiens à l’honneur
www.sciencedirect.com
February 26, 2025 at 7:08 AM
Reposted by Anaïs Roeser
revmedinterne.bsky.social
Prise en charge du purpura thrombotique thrombocytopénique congénital à l’ère de la protéine ADAMTS13 recombinante : recommandations du Centre de référence des microangiopathies thrombotiques (CNR-MAT)

www.sciencedirect.com/science/arti...
Prise en charge du purpura thrombotique thrombocytopénique congénital à l’ère de la protéine ADAMTS13 recombinante : recommandations du Centre de référence des microangiopathies thrombotiques (CNR-MAT...
Thrombotic Thrombocytopenic Purpura (TTP) is a rare disease characterized by a severe deficiency of ADAMTS13, the specific protease that cleaves von W…
www.sciencedirect.com
February 5, 2025 at 7:02 AM
Reposted by Anaïs Roeser
respifil.bsky.social
#PID Anaïs Roeser @hopitalavicenne.bsky.social étude les patterns de progression des PID associées à la sclérodermie systémique.

🔗 doi.org/10.1016/j.rm...
January 26, 2025 at 9:42 AM
Reposted by Anaïs Roeser
revmedinterne.bsky.social
Retrouvez ce mois ci dans la @revmedinterne.bsky.social le portrait du Pr Loïc Raffray, interniste à La Réunion ! 🏝️👨🏽‍⚕️

www.sciencedirect.com/science/arti...
Portrait de Loïc Raffray, PU–PH et chef de service de médecine interne au CHU de La Réunion
www.sciencedirect.com
January 19, 2025 at 7:01 PM
Reposted by Anaïs Roeser
revmedinterne.bsky.social
French protocol for the diagnosis and management of giant cell arteritis
#GCA
doi.org/10.1016/j.re...
Redirecting
doi.org
January 15, 2025 at 7:09 AM
Reposted by Anaïs Roeser
revmedinterne.bsky.social
Use of immunosuppressants and biologics in giant cell arteritis: Recommendations of the French Study Group for Large Vessel Vasculitis (GEFA)
#GCA

doi.org/10.1016/j.re...
Redirecting
doi.org
January 14, 2025 at 7:03 AM
Reposted by Anaïs Roeser
acr-journals.bsky.social
Narrative review examines known associations between environmental exposures and SLE risk through the lens of social determinants of health

In AC&R
doi.org/10.1002/acr....

Social determinants of health determine exposure to many environmental factors, which, in turn, affect risk of SLE
#Medsky
Social determinants of health determine exposure to many environmental factors, which, in turn, affect risk of SLE
January 13, 2025 at 8:49 PM